In the latest from the U.S. Department of Justice (DOJ), the National Fraud Enforcement Division (NFED) announced on October 20, 2026, the creation of a Fraud Whistleblower Incentive Program (WHIP)[1] paying between $10,000 and $30,000 for information leading to criminal charges—to be handed out at the charging stage of a criminal case, as opposed to after the final resolution. This program further incentivizes private whistleblowers to voluntarily disclose potential fraudulent activity. Health care companies, in particular, need to be aware of what this may mean for their businesses.
Recent Updates
- FDA Finalizes Key Parts of Its NDIN Guidance Related to Identity and Safety Information: What Dietary Supplement Companies Should Know
- The Whistleblower Windfall? DOJ Announces Another Incentive Program for Reporting Fraud
- DOJ, HHS Announce One-Stop Shop for Companies Voluntarily Disclosing Potential Health Care Fraud
- DOJ, HHS, CMS Launch an FCA Self-Disclosure Program for Health Care: Who Can Participate, How, and Why
- Psychedelics Move Toward the Mainstream: Lawyers’ Bird’s-Eye View from the Horizons Conference